The Pink Stuff, an all-purpose paste that you can use to clean basically any surface — it works on everything from marble and ...

Speed up your woodworking projects, improve the quality of glue connections and make your project look better with these tips ...

Scientists in Japan constructed the first satellite made of wood by blending age-old woodworking techniques with rocket science. transcript 3, 2, 1. ... and liftoff. By John Yoon and Hisako Ueno ...

This means the archaeological record of human tool use is deeply skewed towards the much hardier stone. All this suggests that the origins of human technology could have been profoundly misunderstood.

This (unfortunately) tends to be the norm with plastic boards over time, as these things aren't built to last nearly as long as a wood or rubber board. That said, Material does offer a lifetime ...

Courtesy of Photo by Matt Payne of Durango, Colorado|Getty Images Many critics, travelers and locals agree that of all of Portland's parks (and they are numerous), Washington Park is perhaps the ...

It resists moisture well and also stands up against temperature fluctuations. You should also be aware of polyurethane-based adhesives. This type of glue works for many different materials including ...

There are four stages of passing a kidney stone: The stone forms, leaves the kidney, reaches the bladder and causes pressure, and finally, exits the body. They're common, with about 10% of people in ...

And as a bonus, they collaborated with an artist who used the resulting ceramic tiles to create a unique art exhibit at the NUS Museum—a striking merger of science and art. As reported ...

The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using the company’s QuEEN platform, that makes ...

The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...

Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with its Phase I ...